L. Aklog et al., TECHNIQUES AND RESULTS OF DIRECT-ACCESS MINIMALLY INVASIVE MITRAL-VALVE SURGERY - A PARADIGM FOR THE FUTURE, Journal of thoracic and cardiovascular surgery, 116(5), 1998, pp. 705-714
Objectives: Our objective was to determine whether direct-access minim
ally invasive mitral valve surgery can improve recovery and cost while
maintaining the efficacy of conventional surgery. Methods: Minimally
invasive mitral valve operations were performed on 106 patients, 58% m
ale, average age 58.1 years, with good ventricular function, Ninety un
derwent repair of a regurgitant, myxomatous valve, and 16 underwent mi
tral valvuloplasty for prematurely calcified mitral stenosis, The valv
e was approached with standard instruments through a 5- to 8-cm right
parasternal incision. Eighty-five had open femoral artery-femoral vein
cannulation, but this technique has recently been replaced by direct
cannulation of the aorta and percutaneous cannulation of the femoral v
ein for most patients. Results: There were no operative deaths, The me
an mitral regurgitation score (0-4) decreased from 3.7 to 0.7 after th
e operation. Although ischemic and bypass times were increased, postop
erative recovery was accelerated. Ventilatory support time, intensive
care unit stay, hospital stay, need for rehabilitation, and return to
''normal activities'' all improved. Hospital charges, pain medications
, and blood transfusions were also reduced. New atrial fibrillation co
ntributed significantly to increased length of stay and charges, There
were no deep wound infections. Other complications included re-explor
ation for bleeding (n = 1), transient ischemic attacks (n = 2), stroke
(n = 1), femoral artery injury (n = 5), pseudoaneurysm (n = 2), and a
ntegrade dissection of the ascending aorta (n = 1). Two patients died
and 1 required reoperation during a mean follow-up of 8.8 months. Conc
lusions: Direct-access minimally invasive mitral valve surgery can acc
elerate recovery, decrease charges, and decrease pain, while maintaini
ng overall surgical efficacy. It has become our standard approach for
isolated primary mitral valve operations.